p53 abnormalities in primary prostate cancer: Single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA

Journal of the National Cancer Institute

Volumn 89, Issue 1, 1997, Pages 66-71

  Gumerlock, Paul H ^a,d   Chi, Sung Gil ^a,e   Shi, Xu Bao ^a   Voeller, H James ^b   Jacobson, James W ^c   Gelmann, Edward P ^b   DeVere White, Ralph W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Kyung Hee University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PROTEIN P53;

ANALYTIC METHOD; ARTICLE; COMPARATIVE STUDY; CYTOGENETICS; GENE FREQUENCY; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PROSTATE CANCER; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 0031029907     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.1.66     Document Type: Article

References (27)

1. Isaacs WB, Carter BS, Ewing CM. Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Res 1991;51:4716-20.
2. Hall MC, Troncosco P, Pollack A, Zagars GK, von Eschenbach AC, Conti CJ, et al. Frequency and characterization of p53 mutations in clinically localized prostate cancer. Urology 1995;45:470-5.
3. Bookstein R, MacGrogan D, Hilsenbeck SG, Sharkey F, Allred DC. p53 is mutated in a subset of advanced-stage prostate cancers. Cancer Res 1993;53:3369-73.
4. Uchida T, Wada C, Shitara T, Egawa S, Koshiba K. Infrequent involvement of p53 gene mutations in the tumourigenesis of Japanese prostate cancer. Br J Cancer 1993;68:751-5.
5. Voeller HJ, Sugars LY, Pretlow T, Gelmann EP. p53 oncogene mutations in human prostate cancer specimens. J Urol 1994;151:492-5.
6. Effert PJ, McCoy RH, Walther PJ, Liu ET. p53 gene alterations in human prostate carcinoma. J Urol 1993;150:257-61.
7. Navone NM, Troncoso P, Pisters LL, Goodrow TL, Palmer JL, Nichols WW, et al. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. J Natl Cancer Inst 1993;85:1657-69.
8. Chi SG, deVere White RW, Meyers FJ, Siders DB, Lee F, Gumerlock PH. p53 in prostate cancer: frequent expressed transition mutations. J Natl Cancer Inst 1994;86:926-33.
9. Bhargava V, Thor A, Deng G, Ljung BM, Moore DH 2nd, Walman F, et al. The association of p53 immunopositivity with tumor proliferation and other prognostic indicators in breast cancer. Mod Pathol 1994;7:361-8.
10. Bosari S, Viale G, Bossi P, Maggioni M, Coggi G, Murray JJ, et al. Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas. J Natl Cancer Inst 1994;86:681-7.
11. Sander CA, Yano T, Clark HM, Harris C, Longo DL:, Jaffe ES, et al. p53 mutation is associated with progression in follicular lymphomas. Blood 1993;82:1994-2004.
12. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci U S A 1989;86:2766-70.
13. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989;5:874-8.
14. Sheffield VC, Beck JS, Kwitek AE, Sanstrom DW, Stone EM. The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics 1993;16:325-32.
15. Hayashi K, Yandell DW. How sensitive is PCR-SSCP? Hum Mutat 1993;2:338-46.
16. Glavac D, Dean M. Optimization of the single-strand conformation polymorphism (SSCP) technique for detection of point mutations. Hum Mutat 1993;2:404-14.
17. Leren TP, Solberg K, Rodningen OK, Ose L, Tonstad S, Berg K. Evaluation of running conditions for SSCP analysis: application of SSCP for detection of point mutations in the LDL receptor gene. PCR Methods Appl 1993;3:159-62.
18. Michaud J, Brody LC, Steel G, Fontaine G, Martin LS, Valle D, et al. Strand-separating conformational polymorphism analysis: efficacy of detection of point mutations in the human ornithine delta-aminotransferase gene. Genomics 1992;13:389-94.
19. Shi XB, Bodner SM, deVere White RW, Gumerlock PH. Identification of p53 mutations in archival prostate tumors: sensitivity of an optimized SSCP assay. Diagn Mol Pathol. In press.
20. Smith TA, Whelan J, Parry PJ. Detection of single-base mutations in a mixed population of cells: a comparison of SSCP and direct sequencing. Genet Anal Tech Appl 1992;9:143-5.
21. Wu JK, Ye A, Darras BT. Sensitivity of single-strand conformation polymorphism (SSCP) analysis in detecting p53 point mutations in tumors with mixed cell populations. Am J Hum Genet 1993;52:1273-5.
22. Saunders KA, Madewell BR, Oreffo VI, Kracgel SA, Gumerlock PH. Nucleotide sequence of canine c-N-ras: codons 1 to 71. Am J Vet Res 1992;53:600-3.
23. Fishman JR, Gumerlock PH, Meyers FJ, de-Vere White RW. Quantitation of NM23 expression in human prostate tissues. J Urol 1994;152:202-7.
24. Madewell BR, Gumerlock PH, Saunders KA, Meyers FJ, Kraegel SA, Kawasaki ES. Canine and bovine Ras family expression detected and discriminated by use of polymerase chain reaction. Anticancer Res 1989;9:1743-9.
25. Catalona WJ. Diagnosis, staging, and surgical treatment of prostatic carcinoma. Arch Intern Med 1987;147:361-3.
26. Mellinger GT, Gleason D, Bailar J 3d. The histology and prognosis of prostatic cancer. J. Urol 1967;97:331-7.
27. Mirchandani D, Zheng J, Miller GJ, Ghosh AK, Shibata DK, Cote RJ, et al. Heterogenity in intratumor distribution of p53 mutations in human prostate cancer. Am J Pathol 1995;147:92-101.